ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+19.54%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$703M
AUM Growth
+$703M
(+0.21%)
Cap. Flow
-$70.9M
Cap. Flow
% of AUM
-10.08%
Top 10 Holdings %
Top 10 Hldgs %
33.38%
Holding
96
New
21
Increased
16
Reduced
32
Closed
21
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$34.1M |
| 2 |
Pinduoduo
PDD
|
$11.7M |
| 3 |
Airbnb
ABNB
|
$10.6M |
| 4 |
ASML
ASML
|
$8.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$8.2M |
Top Sells
| 1 |
Impinj
PI
|
$20M |
| 2 |
Repligen
RGEN
|
$14.7M |
| 3 |
Enphase Energy
ENPH
|
$14.5M |
| 4 |
Datadog
DDOG
|
$12.4M |
| 5 |
Lantheus
LNTH
|
$12.4M |
Sector Composition
| 1 | Healthcare | 32.28% |
| 2 | Technology | 27.77% |
| 3 | Industrials | 11.73% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Communication Services | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Acadia Healthcare
ACHC
$2.12B
| $5.83M | 0.78% |
75,000
-18,000
| -19% | -$1.4M |
|
52
Axsome Therapeutics
AXSM
$6.05B
| $5.31M | 0.71% |
66,700
-4,300
| -6% | -$342K |
|
53
MYR Group
MYRG
$2.91B
| $5.06M | 0.68% |
+35,000
| New | +$5.06M |
|
54
Immunovant
IMVT
$2.56B
| $5.06M | 0.68% |
120,000
-89,000
| -43% | -$3.75M |
|
55
Calix
CALX
$3.88B
| $5.02M | 0.67% |
115,000
+43,000
| +60% | +$1.88M |
|
56
Trump Media & Technology Group
DJT
$4.91B
| $4.37M | 0.58% |
249,499
+139,937
| +128% | +$2.45M |
|
57
Xenon Pharmaceuticals
XENE
$2.98B
| $4.29M | 0.58% |
+93,234
| New | +$4.29M |
|
58
Cytokinetics
CYTK
$4.23B
| $4.26M | 0.57% |
+51,000
| New | +$4.26M |
|
59
ARK Genomic Revolution ETF
ARKG
$1.04B
| $3.58M | 0.48% |
+109,089
| New | +$3.58M |
|
|
CBAY
60
DELISTED
Cymabay Therapeutics
CBAY
| $3.42M | 0.46% |
145,000
+29,000
| +25% | +$685K |
|
61
DigitalBridge
DBRG
$2.08B
| $3.21M | 0.43% |
183,000
-17,000
| -9% | -$298K |
|
62
monday.com
MNDY
$9.95B
| $2.63M | 0.35% |
+14,000
| New | +$2.63M |
|
63
Akero Therapeutics
AKRO
$3.74B
| $1.87M | 0.25% |
+79,935
| New | +$1.87M |
|
64
Adaptive Biotechnologies
ADPT
$2.01B
| $1.62M | 0.22% |
+330,000
| New | +$1.62M |
|
|
FUSN
65
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.25M | 0.17% |
+130,400
| New | +$1.25M |
|
66
Syndax Pharmaceuticals
SNDX
$1.41B
| $864K | 0.12% |
+40,000
| New | +$864K |
|
67
Viridian Therapeutics
VRDN
$1.5B
| $849K | 0.11% |
+39,000
| New | +$849K |
|
68
Elanco Animal Health
ELAN
$9.12B
| $745K | 0.1% |
50,000
-154,900
| -76% | -$2.31M |
|
69
BridgeBio Pharma
BBIO
$9.89B
| $363K | 0.05% |
+9,000
| New | +$363K |
|
|
70
Datadog
DDOG
$47.7B
| – | – |
-136,000
| Closed | -$12.4M |
|
71
C3.ai
AI
$2.33B
| – | – |
0
| – | – |
|
72
Albemarle
ALB
$9.99B
| – | – |
-26,550
| Closed | -$4.51M |
|
73
Chegg
CHGG
$159M
| – | – |
0
| – | – |
|
74
CommScope
COMM
$3.55B
| – | – |
0
| – | – |
|
75
Coty
COTY
$3.73B
| – | – |
-510,785
| Closed | -$5.6M |
|